BioMedTech January 15, 2019 Positive interim results from the first part of the PIVOTAL study Positive interim results from the first part of the PIVOTAL study (10 patients) ...
BioMedTech January 1, 2019 Les Echos, Investir | Deinove leaps onto the stock market, the American army demonstrates the effectiveness of its antibiotic against bioterrorism
BioMedTech October 16, 2018 Pharnext announces positive results from the pivotal Phase 3 trial of PXT3003 for the treatment of Charcot-Marie-Tooth disease type 1A
